GENE ONLINE|News &
Opinion
Blog

Funding
In-Home Kidney Disease Management Company, Monogram, Raises $375 Million
2023-01-13
Belharra Therapeutics Exits Stealth With $130 Million And A Genentech Deal
2023-01-05
Zenas Picks Up $118 Million To Advance Phase 3 For Autoimmune Candidate
2022-11-10
Nineteen Grants and Two Contracts Grab $38 Million In Support From the FDA
2022-10-17
Andera Partners Drums Up $443 Million For Its Largest Life Sciences Fund
2022-10-11
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Theravance Allots $250 Million to Repurchase Shares, Removing GSK as a Shareholder
2022-09-20
Big Pharma-Backed Capstan Launches With $165 Million To Combine Cell Therapy And mRNA Technology
2022-09-15
Forge Biologics Raises $90 Million To Expand Gene Therapy CDMO
2022-09-14
Series D Funding Brings Radiopharmaceutical Company RayzeBio to $418 million in Total
2022-09-13
Pretzel Therapeutics Starts Off With $72.5 Million To Modify Mitochondria
2022-09-13
Competing With BMS’s New Psoriasis Drug, Nimbus Gathers $125 Million to Advance Development
2022-09-13
RNA-Focused Orbital Therapeutics Makes its Industry Debut with Beam Partnership
2022-09-08
NC – Life Sciences Manufacturing Coalition Wins $25 million in Grant Funding
2022-09-02
NIH Provides $23 Million to Fund Telehealth Cancer Care Research
2022-08-22
1 2 3 10
LATEST
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!